Catalyst Pharmaceuticals Inc (CPRX)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 623,609 | 219,329 | 320,797 | 210,106 | 159,244 |
| Total current liabilities | US$ in thousands | 120,678 | 76,063 | 57,588 | 27,063 | 22,756 |
| Current ratio | 5.17 | 2.88 | 5.57 | 7.76 | 7.00 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $623,609K ÷ $120,678K
= 5.17
The current ratio of Catalyst Pharmaceuticals Inc has exhibited fluctuations over the past five years. As of December 31, 2020, the company had a current ratio of 7.00, indicating a strong ability to meet its short-term obligations with current assets. This ratio increased to 7.76 by December 31, 2021, further solidifying the company's liquidity position.
However, there was a notable decrease in the current ratio to 5.57 by December 31, 2022, which may raise concerns about the company's short-term liquidity. The ratio further declined to 2.88 by December 31, 2023, indicating a potentially strained liquidity position.
By December 31, 2024, the current ratio improved to 5.17, suggesting a partial recovery in the company's ability to cover its short-term liabilities with current assets. Overall, the fluctuation in Catalyst Pharmaceuticals Inc's current ratio warrants closer monitoring to assess the company's liquidity management and financial health.
Peer comparison
Dec 31, 2024